Amicus Therapeutics
FOLD
#3324
Rank
A$6.43 B
Marketcap
A$20.52
Share price
0.14%
Change (1 day)
31.61%
Change (1 year)

Amicus Therapeutics (FOLD) Fails to deliver data

Key failure to deliver metrics for Amicus Therapeutics :

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Amicus Therapeutics (FOLD) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Amicus Therapeutics (FOLD) - since 2013

Volume in USD (price x number of shares), data since 2013

Amicus Therapeutics (FOLD) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2026A$0.18 M-98.97%
2025A$17.89 M205.88%
2024A$5.85 M56.18%
2023A$3.74 M-55.9%
2022A$8.49 M17.92%
2021A$7.2 M-82.17%
2020A$40.39 M-25.02%
2019A$53.87 M65.54%
2018A$32.54 M14.55%
2017A$28.41 M-25.82%
2016A$38.3 M-25.86%
2015A$51.66 M162.72%
2014A$19.66 M1873.58%
2013A$0.99 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3 months) FTD volume (1 year) Country
Novo Nordisk
NVO
A$0.13 BA$0.38 B๐Ÿ‡ฉ๐Ÿ‡ฐ Denmark
Biogen
BIIB
A$3.4 MA$75.76 M๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
A$48.95 MA$0.36 B๐Ÿ‡ฌ๐Ÿ‡ง UK
Lexicon Pharmaceuticals
LXRX
A$1.5 MA$12.43 M๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
A$4.76 MA$11 M๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
A$8.34 MA$13.64 M๐Ÿ‡บ๐Ÿ‡ธ USA